SEC Form 4 · accession 0000907654-26-000066
Oruka Therapeutics, Inc. · ORKA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Arjun Agarwal
Officer — Senior Vice President, Finance
Period of report
Jun 22, 2026
Accepted (ET)
Jun 22, 2026 · 7:59 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0000907654
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 22, 2026 | S | 888 | $80.01 | D | 16,011 | D | |
| Common Stock | Jun 22, 2026 | S | 699 | $82.145 | D | 15,312 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 11, 2026.